Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial of IBIO-CFB03 for treatment of fibrotic diseases

Next Previous
Trial Profile

A phase I trial of IBIO-CFB03 for treatment of fibrotic diseases

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs IBIO CFB03 (Primary)
  • Indications Pulmonary fibrosis
  • Focus Adverse reactions

    • Most Recent Events

    • 05 Jul 2016 According to an iBio Inc media release, the company has announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to iBio-CFB03, for the treatment of systemic sclerosis.
    • 23 Sep 2015 New trial record
    • 09 Sep 2015 According to an iBio Inc media release, this trial has been funded by a grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) under its Small Business Technology Transfer (STTR) program.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top